The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of gemcitabine plus rapamycin as second line in advanced osteosarcoma: A Spanish Group for Sarcoma Research (GEIS) Study.
 
Javier Martin Broto
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; PharmaMar
 
Andrés Redondo
No Relationships to Disclose
 
Claudia María Valverde
No Relationships to Disclose
 
María Ángeles Vaz Salgado
No Relationships to Disclose
 
Jaume Mora
No Relationships to Disclose
 
Xavier Garcia del Muro
No Relationships to Disclose
 
Maria Pilar Sancho Marquez
No Relationships to Disclose
 
Javier Martinez-Trufero
No Relationships to Disclose
 
Robert Diaz Beveridge
No Relationships to Disclose
 
Antonio Gutierrez
No Relationships to Disclose
 
Pilar Blay
No Relationships to Disclose
 
Cristina Tous
No Relationships to Disclose
 
Pablo Luna Fra
No Relationships to Disclose
 
Antonio Lopez-Pousa
No Relationships to Disclose